Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
Follow Us linked In
2023 March
  • Home
  • Archive for March, 2023
  • March 29, 2023

Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1

Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1 (March 29, 2023) | By Ana Mulero. Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase

Continue Reading
  • March 28, 2023

The Microbiome Mavericks: How These Startups Are Rewriting the Rules of Medicine and Health.

The Microbiome Mavericks: How These Startups Are Rewriting the Rules of Medicine and Health.

Continue Reading
  • March 28, 2023

Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B

Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B (March 28, 2023) | By Rosemary Scott. Bicycle Therapeutics and Novartis announced Tuesday they have inked a deal worth up to $1.7 billion to discover and

Continue Reading
Engineers Versus Scientists ChatGPT
Blog Grid Microbiome Mining
  • March 24, 2023

Engineers Versus Scientists ChatGPT

By Ross Youngs, March 24, 2023. Engineers Versus Scientists ChatGPT Just some leading questions to ChatGPT with responses and pushback. A fun Friday read. I am focused on executing a new

Continue Reading
  • March 21, 2023

With CTLA-4 Antibody Deal, BioNTech Comes Face-to-Face with BMS’ Yervoy

With CTLA-4 Antibody Deal, BioNTech Comes Face-to-Face with BMS’ Yervoy (March 21, 2023) | By Tristan Manalac. Monday, BioNTech inked an exclusive worldwide license and collaboration agreement with Maryland-based biopharma

Continue Reading
  • March 20, 2023

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs Collaboration will leverage CHARM’s DragonFold deep learning platform to identify compounds against targets

Continue Reading
  • March 14, 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share for a total enterprise value of

Continue Reading
  • March 8, 2023

2023 Biotechnology Conference

2023 Biotechnology Conference

Continue Reading
Natural Small Molecule Complexity - Evolution Keeps What Works
Blog Grid Microbiome Mining
  • March 5, 2023

Natural Small Molecule Complexity – Evolution Keeps What Works

By Ross Youngs, March 5, 2023. Natural Small Molecule Complexity – Evolution Keeps What Works For decades the promise of obtaining the genetic codes of organisms created a narrative that cures

Continue Reading

RSS Industry News

  • A subset of viruses thrives following microbial resuscitation during rewetting of a seasonally dry California grassland soil September 20, 2023
  • Recovery of the gut microbiome following enteric infection and persistence of antimicrobial resistance genes in specific microbial hosts September 19, 2023
  • Ecophysiology and interactions of a taurine-respiring bacterium in the mouse gut September 18, 2023
  • Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia September 16, 2023
  • A mucin-­foraging bacterium modulates breakdown of oral tolerance September 15, 2023
  • Growth phase estimation for abundant bacterial populations sampled longitudinally from human stool metagenomes September 14, 2023
  • Request for public discussion and ballot to amend SeqCode rules on priority of Candidatus names and correction of typographic and orthographic errors September 14, 2023
  • Pioneering microbiome engineering September 12, 2023
  • The oral microbiome: diversity, biogeography and human health September 12, 2023
  • Oxytetracycline and heavy metals promote the migration of resistance genes in the intestinal microbiome by plasmid transfer September 12, 2023
Awesome Image
Biosortia Microbiomics provides small molecules, datasets, & other opportunities from our deep access to the hidden small molecules in microbiomes.
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • BRAND VOICE RUNWAY with Hersh Rephun (Season 1) Episode 9
  • Ginkgo Bioworks and Google Cloud Partner to Build Next Generation AI Platform for Biological Engineering and Biosecurity
  • Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2023. All Rights Reserved